NCT02402244
Project: Every Child for Younger Patients With Cancer
At risk: Primary completion moved 2 years later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
The 50 most recent of 51 versions: 47 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Dec 31, 2030 to Dec 31, 2032
- Eligibility criteria expanded, about 20 words
- Study sites revised (279)
- Minor Study sites: 278 to 279v50
- Minor Study sites revised (278)v49
- Minor Study sites: 276 to 278v48
- Minor Study sites: 275 to 276v47
Show 42 earlier versionsHide 42 earlier versions
- Minor Study sites: 274 to 275v46
- Minor Study sites: 273 to 274v45
- Minor Study sites: 242 to 273v44
- Minor Study sites revised (242)v43
Notable Enrollment target: 33000 to 75000v42 Show 4 more changesShow less
- Eligibility criteria expanded, about 14 words
- Study description expanded, about 98 words
- Study sites revised (242)
- Study arms: 1 to 2
- Minor Site contacts updated at 2 of 242 sitesv41
- Minor Study sites revised (242)v40
- Minor Study sites revised (242)v39
- Minor Study sites revised (242)v38
- Minor Site details revised at 1 of 242 sitesv37
- Minor Site details revised at 10 of 242 sitesv36
- Notable Eligibility criteria expanded, about 14 words
- Start date: Oct 26, 2015 to Nov 3, 2015
- Site contacts updated at 1 of 242 sites
- Notable Primary and study completion dates: Dec 31, 2025 to Dec 31, 2030v34
- Minor Study sites revised (242)v33
- Minor Site details revised at 2 of 242 sitesv32
- Minor Study sites: 241 to 242v31
- Minor Site details revised at 9 of 241 sitesv30
- Minor Site details revised at 6 of 241 sitesv29
- Minor Study sites revised (241)
- Study description expanded, about 2 words
- Minor Study sites: 240 to 241v27
- Minor Site details revised at 1 of 240 sitesv26
- Minor Study sites: 239 to 240v25
- Minor Site details revised at 11 of 239 sitesv24
- Minor Site details revised at 15 of 239 sitesv23
- Minor Study sites: 238 to 239v22
- Minor Study sites: 237 to 238
- Study completion date: Dec 31, 2025
- Minor Site details revised at 13 of 237 sitesv20
- Minor Study sites: 236 to 237v19
- Minor Site details revised at 13 of 236 sitesv18
- Minor Site details revised at 11 of 236 sitesv17
- Minor Study sites revised (236)v16
- Minor Site details revised at 10 of 236 sitesv15
- Minor Study sites: 235 to 236v14
- Notable Primary endpoint revised
- Study sites revised (235)
- Notable Primary completion date: Dec 14, 2020 to Dec 31, 2025
- Study sites: 228 to 235
- Eligibility criteria revised
- Study description shortened, about 2 words
- Minor Study sites revised (228)v11
- Minor Study sites: 224 to 228v10
Notable Trial status: Active, Not Recruiting to Recruitingv9 Show 6 more changesShow less
- Primary completion date: Jan 2100 to Dec 14, 2020
- Eligibility criteria expanded, about 108 words
- Primary endpoint revised
- Study sites: 211 to 224
- Start date: Oct 2015 to Oct 26, 2015
- Interventions: cytology specimen collection procedure (Other) to Cytology Specimen Collection Procedure (Other), Medical Chart Review (Other)
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 211 of 211 sites
- Minor Site details revised at 7 of 211 sitesv7
- Minor Study sites: 1 to 211v6
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Jun 2015 to Oct 2015
- Site details revised
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Patients undergo collection of biospecimen samples (e.g., tissue, blood, bone marrow, plasma, serum, buccal swab, saliva, cerebrospinal fluid, or urine).
Patients undergo medical data review to create a Childhood Cancer Registry. Patients also undergo collection of biospecimen samples (e.g., tissue, blood, bone marrow, plasma, serum, buccal swab, saliva, cerebrospinal fluid, or urine).
Other: Cytology Specimen Collection Procedure, Medical Chart Review
Sites
279 sites in 6 countries
United States 246, Canada 17, Australia 10, Puerto Rico 3, New Zealand 2, Saudi Arabia 1